FRCPath Haem part 1 MCQ-Oncology 381
- amirhayat2527
- 2 days ago
- 0 min read
A 50-year-old man with HCL received Pentostatin first-line, achieved CR, but relapsed after 18 months. Next best treatment?
Rituximab monotherapy
Moxetumumab Trial
Re-treat with Pentostatin
Re-treat with Pentostatin and Add Rituximab


Correct Answer: Cladribine
This is classic hairy cell leukaemia (HCL) management.
Key points:
He received Pentostatin first-line → achieved CR
Relapse at 18 months = early relapse (<2 years)
What that means
CR lasting >2 years:
Re-treat with same agent & can add Rituximab to either
CR lasting <2 years:
Whichever purine analogue wasn’t use first line
👉 Next best treatment
Cladribine ( but cladribine + rituximab is most commonly cited)